Clinical Trials for Precursor Cell Lymphoblastic Leukemia-Lymphoma

Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...

NCT ID: NCT02390752

This clinical trial is studying a medication called TURALIO® (pexidartinib) to see if it can help shrink or stop the growth of certain types of cancer in children and young adults aged 3 to 35. The...

Pediatric-inspired Regimen Combined With Venetoclax for Adolescent and Adult Patients With de Novo Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia

NCT ID: NCT05660473

This clinical trial is studying a new treatment approach for adolescents and adults with a specific type of leukemia called Philadelphia chromosome-negative acute lymphoblastic leukemia (Ph- ALL). ...

Efficacy and Safety of Low-dose Chemotherapy Plus Immuno-targeted Drugs in Newly Diagnosed Elderly/Unfit Ph- B-ALL

NCT ID: NCT06387121

This clinical trial is studying a new treatment approach for elderly or unfit patients who have just been diagnosed with a specific type of leukemia called Ph-negative B-cell acute lymphoblastic le...

Effectiveness of Probiotics for the Prevention of Gastrointestinal Toxicity in Children with Leukemia

NCT ID: NCT06560879

CART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: a Dose Escalation Phase I Trial

NCT ID: NCT06765876

This clinical trial is testing a new treatment called CART123 T cells for adults with certain types of blood cancers that have not responded to previous treatments. These cancers include acute myel...

Phase I Clinical Trial of CART Cell Therapy for Refractory/Relapsed Acute Lymphoblastic Leukemia in Children, Adolescents and Young Adults

NCT ID: NCT06709469

This clinical trial is studying a new treatment called CART cell therapy for children, adolescents, and young adults with a specific type of leukemia that has not responded to standard treatments. ...

Safety of INT2104 in Participants Aged 18 Years and Older Who Have B-cell Cancer That Came Back After Prior Treatment

NCT ID: NCT06539338

This clinical trial is studying a new treatment called INT2104 for adults aged 18 and older who have certain types of B-cell cancers, such as non-Hodgkin lymphoma or acute lymphoblastic leukemia, t...

Glucose Intolerance and Diabetes Related to Treatment With Steroids and PEG- Asparaginase in Children and Adolescents With ALL and Lymphoma

NCT ID: NCT05873322

**Clinical Trial Summary: Glucose Intolerance and Diabetes Related to Treatment With Steroids and PEG-Asparaginase in Children and Adolescents With ALL and Lymphoma** This clinical trial is studyi...

MRD-associated Non-intensive But Non-interruptive Treatment of Ph-negative Acute Lymphoblastic Leukemia Adult Patients

NCT ID: NCT06237192

This clinical trial is studying a new treatment approach for adults with a type of blood cancer called Ph-negative acute lymphoblastic leukemia (ALL). The goal is to find out if a non-intensive tre...